M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth by Cortés-Cros, Marta, Hemmerlin, Christelle, Ferretti, Stephane, Zhang, Juan, Gounarides, John S., Yin, Hong, Muller, Alban, Haberkorn, Anne, Chene, Patrick, Sellers, William R., Hofmann, Francesco

Get full text

Condensation Domain Editing of the FR900359 Assembly Line Yields a Novel Analog Amenable to Late‐Stage Functionalization by Pistorius, Dominik, Richard, Etienne, Buntin, Kathrin, Dresen, Kathrin, Wollbrett, Séverine, Weber, Eric, Haberkorn, Anne, Manchado, Eusebio, Petersen, Frank

Get full text

SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors by Lu, Hengyu, Liu, Chen, Velazquez, Roberto, Wang, Hongyun, Dunkl, Lukas Manuel, Kazic-Legueux, Malika, Haberkorn, Anne, Billy, Eric, Manchado, Eusebio, Brachmann, Saskia M, Moody, Susan E, Engelman, Jeffrey A, Hammerman, Peter S, Caponigro, Giordano, Mohseni, Morvarid, Hao, Huai-Xiang

Get full text

Promoter‐Driven Overexpression in Chromobacterium vaccinii Facilitates Access to FR900359 and Yields Novel Low Abundance Analogs by Pistorius, Dominik, Buntin, Kathrin, Weber, Eric, Richard, Etienne, Bouquet, Caroline, Wollbrett, Séverine, Regenass, Hugo, Peón, Victor, Böhm, Marcel, Kessler, Régis, Gempeler, Thomas, Haberkorn, Anne, Wimmer, Laurin, Lanshoeft, Christian, Davis, John, Hainzl, Dominik, D'Alessio, Joseph Anthony, Manchado, Eusebio, Petersen, Frank

Get full text

Abstract A44: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors by Lu, Hengyu, Liu, Chen, Velazquez, Roberto, Wang, Hongyun, Dunkl, Lukas M., Kazic-Legueux, Malika, Haberkorn, Anne, Billy, Eric, Manchado, Eusebio, Brachmann, Saskia M., Moody, Susan, Engelman, Jeffrey A., Hammerman, Peter S., Caponigro, Giordano, Mohseni, Morvarid, Hao, Huai-Xiang

Get full text

Abstract 954: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors by Lu, Hengyu, Liu, Chen, Velazquez, Roberto, Wang, Hongyun, Dunkl, Lukas M., Kazic-Legueux, Malika, Haberkorn, Anne, Billy, Eric, Manchado, Eusebio, Brachmann, Saskia M., Moody, Susan, Engelman, Jeffrey A., Hammerman, Peter S., Caponigro, Giordano, Mohseni, Morvarid, Hao, Huaixiang

Get full text

RETRACTED: 60 Predicting chorioamnionitis using AI-based methods: a retrospective cohort study by Waldrop, Anne R., James, Tomin K., Suharwardy, Sanaa, Studer, Manual, Chang, Alan, Bernal, Camilo Espinosa, Xie, Feng, Shome, Sayane, Hazra, Debapriya, Kim, Yera, Clarke, Geetha, Chakraborty, Dipro, Mataraso, Samson, Berson, Eloise, Xue, Lei, Payrovnaziri, Seyedeh, Mohammadi, Neshat, Haberkorn, William, Maric, Ivana, El-Sayed, Yasser Y., Carvalho, Brendan, Aghaeepour, Nima

Get full text

First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas by Dittmar, Jan Oliver, Kratochwil, Clemens, Dittmar, Anne, Welzel, Thomas, Habermehl, Daniel, Rieken, Stefan, Giesel, Frederik L, Haberkorn, Uwe, Debus, Jürgen, Combs, Stephanie E

Get full text

Biome changes in Asia since the mid-Holocene – an analysis of different transient Earth system model simulations by Dallmeyer, Anne, Claussen, Martin, Ni, Jian, Cao, Xianyong, Wang, Yongbo, Fischer, Nils, Pfeiffer, Madlene, Jin, Liya, Khon, Vyacheslav, Wagner, Sebastian, Haberkorn, Kerstin, Herzschuh, Ulrike

Get full text

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients by Will, Leon, Giesel, Frederik L., Freitag, Martin T., Berger, Anne K., Mier, Walter, Kopka, Klaus, Koerber, Stefan A., Rathke, Hendrik, Kremer, Christophe, Kratochwil, Clemens, Kauczor, Hans-Ulrich, Haberkorn, Uwe, Weber, Tim F.

Get full text

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era by Wensink, G Emerens, Elferink, Marloes A G, May, Anne M, Mol, Linda, Hamers, Patricia A H, Bakker, Sandra D, Creemers, Geert-Jan, de Groot, Jan Willem B, de Klerk, Gerty J, Haberkorn, Brigitte C M, Haringhuizen, Annebeth W, Hoekstra, Ronald, Hunting, J Cornelis B, Kerver, Emile D, Mathijssen-van Stein, Danielle, Polée, Marco B, Pruijt, Johannes F M, Quarles van Ufford-Mannesse, Patricia, Radema, Sandra, Rietbroek, Ronald C, Simkens, Lieke H J, Tanis, Bea C, Ten Bokkel Huinink, Daan, Tjin-A-Ton, Manuel L R, Tromp-van Driel, Cathrien S, Troost, Monique M, van de Wouw, Agnes J, van den Berkmortel, Franchette W P J, van der Pas, Anke J M, van der Velden, Ankie M T, van Dijk, Marjan A, van Dodewaard-de Jong, Joyce M, van Druten, Edith B, van Voorthuizen, Theo, Jan Veldhuis, Gerrit, Verheul, Henk M W, Vestjens, Hanneke J H M J, Vincent, Jeroen, Kranenburg, Onno W, Punt, Cornelis J A, Vink, Geraldine R, Roodhart, Jeanine M L, Koopman, Miriam

Get full text

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium by de Joode, Karlijn, Tol, Jolien, Hamberg, Paul, Cloos, Marissa, Kastelijn, Elisabeth A., Borgers, Jessica S.W., Nuij, Veerle J.A.A., Klaver, Yarne, Herder, Gerarda J.M., Mutsaers, Pim G.N.J., Dumoulin, Daphne W., Oomen-de Hoop, Esther, van Diemen, Nico G.J., Libourel, Eduard J., Geraedts, Erica J., Bootsma, Gerben P., van der Leest, Cor H., Peerdeman, Anne L., Herbschleb, Karin H., Visser, Otto J., Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., de Vries, Elisabeth G.E., Hendriks, Lizza E.L., Beerepoot, Laurens V., Westgeest, Hans M., van den Berkmortel, Franchette W.P.J., Haanen, John B.A.G., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., Becker-Commissaris, A., Terheggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Strobbe, L., Koekkoek, J.A.F., Brocken, P., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., van 't Westeinde, S.C., Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H.

Get full text

Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the p... by Berger, Anne Katrin, Lücke, Stephan, Abel, Ulrich, Haag, Georg Martin, Grüllich, Carsten, Stange, Annika, Dietrich, Mareike, Apostolidis, Leonidas, Freitag, Angelika, Trierweiler, Claudia, von Gall, Carl, Ose, Jennifer, Giesel, Frederik, Weber, Tim Frederik, Lordick, Florian, Haberkorn, Uwe, Jäger, Dirk

Get full text

High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab by Weber, Tobias, Bötticher, Benedikt, Mier, Walter, Sauter, Max, Krämer, Susanne, Leotta, Karin, Keller, Armin, Schlegelmilch, Anne, Grosse-Hovest, Ludger, Jäger, Dirk, Haberkorn, Uwe, Arndt, Michaela A E, Krauss, Jürgen

Get full text

High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a ^sup 177^Lu-based CD22-specific radioimmunoconjugate and rituximab by Weber, Tobias, Bötticher, Benedikt, Mier, Walter, Sauter, Max, Krämer, Susanne, Leotta, Karin, Keller, Armin, Schlegelmilch, Anne, Grosse-hovest, Ludger, Jäger, Dirk, Haberkorn, Uwe, Arndt, Michaela A, E, Krauss, Jürgen

Get full text

High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a super(177)Lu-based CD22-specific radioimmunoconjugate and rituximab by Weber, Tobias, Botticher, Benedikt, Mier, Walter, Sauter, Max, Kraemer, Susanne, Leotta, Karin, Keller, Armin, Schlegelmilch, Anne, Grosse-Hovest, Ludger, Jaeger, Dirk, Haberkorn, Uwe, Arndt, Michaela AE, Krauss, Juergen

Get full text

High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab by Weber, Tobias, Bötticher, Benedikt, Mier, Walter, Sauter, Max, Krämer, Susanne, Leotta, Karin, Keller, Armin, Schlegelmilch, Anne, Grosse-Hovest, Ludger, Jäger, Dirk, Haberkorn, Uwe, Arndt, Michaela A. E., Krauss, Jürgen

Get full text

A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer... by Berger, Anne Katrin, von Gall, Carl, Abel, Ulrich, Delorme, Stefan, Kloor, Matthias, Ose, Jennifer, Weber, Tim Frederik, Stange, Annika, Haag, Georg Martin, Haberkorn, Uwe, Lordick, Florian, Jäger, Dirk

Get full text

Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression by BRUST, Peter, HAUBNER, Roland, SCHACKERT, Gabriele, SCHACKERT, Hans K, AVRIL, Norbert, JOHANNSEN, Bernd, FRIEDRICH, Anne, SCHEUNEMANN, Matthias, ANTON, Martina, KOUFAKI, Olga-Niki, HAUSES, Martin, NOLL, Steffi, NOLL, Bernhard, HABERKORN, Uwe

Get full text

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer by van Nassau, Sietske C, Bond, Marinde J, Scheerman, Ilva, van Breeschoten, Jesper, Kessels, Rob, Valkenburg-van Iersel, Liselot B, Verheul, Henk M, Buffart, Tineke E, Mekenkamp, Leonie J, Lemmens, Valery E, Koopman, Miriam, Bol, Guus M

Get full text